BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vervliet T, Yule DI, Bultynck G. Carbohydrate Loading to Combat Acute Pancreatitis. Trends Biochem Sci 2018;43:741-4. [PMID: 30170888 DOI: 10.1016/j.tibs.2018.08.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Jakubowska MA, Kerkhofs M, Martines C, Efremov DG, Gerasimenko JV, Gerasimenko OV, Petersen OH, Bultynck G, Vervliet T, Ferdek PE. ABT-199 (Venetoclax), a BH3-mimetic Bcl-2 inhibitor, does not cause Ca2+ -signalling dysregulation or toxicity in pancreatic acinar cells. Br J Pharmacol 2019;176:4402-15. [PMID: 30266036 DOI: 10.1111/bph.14505] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
2 Kerkhofs M, Bultynck G, Vervliet T, Monaco G. Therapeutic implications of novel peptides targeting ER-mitochondria Ca2+-flux systems. Drug Discov Today 2019;24:1092-103. [PMID: 30910738 DOI: 10.1016/j.drudis.2019.03.020] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]